Boston Scientific posts positive data for coronary IVL catheter

With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for patients with severely calcified coronary artery disease.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top